EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A

Dandan Feng, Jie Gao iD, Ruiqiong Liu iD, Wei Liu, Tianyang Gao, Yunkai Yang, Die Zhang, Tianshu Yang, Xin Yin, Hefen Yu iD, Wei Huang iD, Yan Wang iD

Protein & Cell · 01.10.2024 · 15 (10) · 744-765

DOI: 10.1093/procel/pwae010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein & Cell, online erschienen am 13.03.2024. Verfasst von Dandan Feng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Cancer and Microbiome, State Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Ca…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Hypoxia-Inducible Factor 1, alpha Subunit, Protein-Arginine N-Methyltransferases, Cell Proliferation. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coactivator-associated arginine methyltransferase 1 (CARM1) promotes the development and metastasis of estrogen receptor alpha (ERα)-positive breast cancer. The function of CARM1 in triple-negative breast cancer (TNBC) is still unclear and requires further exploration. Here, we report that CARM1 promotes proliferation, epithelial–mesenchymal transition, and stemness in TNBC. CARM1 is upregulated in multiple cancers and its expression correlates with breast cancer progression. Genome-wide analysis of CARM1 showed that CARM1 is recruited by hypoxia-inducible factor-1 subunit alpha (HIF1A) and occupy the promoters of CDK4, Cyclin D1, β-Catenin, HIF1A, MALAT1, and SIX1 critically involved in cell cycle, HIF-1 signaling pathway, Wnt signaling pathway, VEGF signaling pathway, thereby modulating the proliferation and invasion of TNBC cells. We demonstrated that CARM1 is physically associated with and directly interacts with HIF1A. Moreover, we found that ellagic acid, an inhibitor of CARM1, can suppress the proliferation and invasion of TNBC by directly inhibiting CDK4 expression. Our research has determined the molecular basis of CARM1 carcinogenesis in TNBC and its effective natural inhibitor, which may provide new ideas and drugs for cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsHypoxia-Inducible Factor 1, alpha SubunitProtein-Arginine N-MethyltransferasesCell ProliferationHumansFemaleCell Line, TumorDisease ProgressionAnimalsMiceEpithelial-Mesenchymal TransitionGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

CARM1CDK4HIF1ATNBCellagic acid

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitProtein-Arginine N-Methyltransferasescoactivator-associated arginine methyltransferase 1HIF1A protein, human

Autor:innen und Institutionen

  • Key Laboratory of Cancer and Microbiome, State Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking…
  • Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
  • Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan 250033, China.
  • Department of Cancer Center, The Second Hospital of Shandong University, Jinan 250033, China.
  • Beijing Key Laboratory of Cancer Invasion and Metastasis Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.

ORCID-Profile: Jie Gao, Ruiqiong Liu, Hefen Yu, Wei Huang, Yan Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Feng, D., Gao, J., Liu, R., Liu, W., Gao, T., Yang, Y., Zhang, D., Yang, T., Yin, X., Yu, H., Huang, W., & Wang, Y. (2024). CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A. Protein & Cell, 15(10), 744-765. https://doi.org/10.1093/procel/pwae010

Vancouver

Feng D, Gao J, Liu R, Liu W, Gao T, Yang Y, et al. CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A. Protein & Cell. 2024;15(10):744-765. doi:10.1093/procel/pwae010

BibTeX
@article{Feng2024,
  author = {Feng, Dandan and Gao, Jie and Liu, Ruiqiong and Liu, Wei and Gao, Tianyang and Yang, Yunkai and Zhang, Die and Yang, Tianshu and Yin, Xin and Yu, Hefen and Huang, Wei and Wang, Yan},
  title = {CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A},
  journal = {Protein & Cell},
  year = {2024},
  volume = {15},
  number = {10},
  pages = {744--765},
  doi = {10.1093/procel/pwae010}
}
Kostenlos starten →